Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2013


Life Science R&D Big Data Leaders Forum

03 Dec 2013 - 05 Dec 2013 - Ramada Plaza Basel, Switzerland



Bookmark and Share


This 3 day forum is the “must attend” event for those senior decision-makers looking to make the shift towards big data and for those looking to improve their implementation of data-driven approaches for their specific departments.

The first day will feature several keynote presentations from C-Level thought leaders on big data in the R&D space and heads of major research institutions who are at the front-end of the big data challenge. They will be discussing the strategic drivers for big data and key implementation guidance on how to make best use of this approach.

Day 2&3 of the Forum will feature 3 specific streams depending on the phase of R&D that is most crucial for you:

-              Discovery & Translational Big Data Forum;

-              Clinical Data Management Forum;

-              Real-World & Health Outcomes Big Data Forum.

Discovery & Translational Big Data Forum will be focusing on important issues related to use of big data to support various functions within the drug discovery process, including better designing NMEs, re-engineering and re-initiating previously failed drug programs and will enable participants to make the most informed decisions possible on how to enhance the management and application of their discovery and translational data. Clinical Data Management Forum will explore a number of areas vital to the development of clinical data management (CDM) and present key issues in selecting and implementing a CDM system. Real-World & Health Outcomes Big Data Forum will discover how to best design observational studies to get most of the real world data generated, what are the new and innovative approaches to capture, store and manage as well as what is the role of evidence and health outcomes data in decision-making.

To request the full agenda please follow the link:

http://bigdata2013.nextlevelpharma.com/request-agenda

Erika Vavrovicova

Life science Big Data Leaders Forum

Tel: +421 232 660 382

Fax: +421 2 3301 0331
Email: erika@nextlevellifesciences.com

Visit: bigdata2013.nextlevelpharma.com



Further information
Scientific News
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
UTSW Researchers Identifies How Drugs Alter Pancreatic Cancer Cells
The findings were published in Cell Reports.
Researchers Identify Process that Causes Chronic Neonatal Lung Disease
Study determines how the NLRP3 inflammasome activates the protein Interleukin 1 beta.
Dengue Vaccine Enters Phase 3 Trial
Investigational vaccine to prevent ‘breakbone fever’ developed at NIH.
Trying to Conceive Soon After a Pregnancy Loss May Increase Chances of Live Birth
NIH study finds no reason for delaying pregnancy attempts after a loss without complications.
BRCA1 Deficiency Increases the Sensitivity of Ovarian Cancer Cells to Auranofin
An anti-rheumatic drug could improve the prognosis for ovarian cancer patients exhibiting a deficiency of the DNA repair protein BRCA1, a study suggests.
Shingles Vaccine Helps Protect Older Patients with End-stage Renal Disease
Kaiser Permanente study advances knowledge about safety and effectiveness of vaccine commonly given to older adults.
AMRI Acquires Whitehouse Laboratories
Strategically extends AMRI's analytical offerings in rapidly expanding area of outsourcing services.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!